News

RHHBY

Abpro Files for $60 Million IPO to Develop Antibody Therapeutics for Cancer and Vascular Eye Diseases

Edward Kim | Equities.com |

Initial targets are HER2+ solid tumors and diabetic macular edema.


Genentech Has Positive Phase 3 Data for First-Line Lung Cancer Treatment

Edward Kim | Equities.com |

Potential first-line therapy for advanced squamous non-small cell lung cancer (Image: Live Science)


Kazia Gets Orphan Drug Designation for Investigational Glioblastoma Multiforme Drug

Edward Kim | Equities.com |

Glioblastoma multiforme is the most common, most aggressive form of primary brain cancer (Image: Rare Disease Report).


GE Healthcare and Roche Partner to Develop Digital Diagnostics for Cancer and Critical Care

Edward Kim | Equities.com |

Industry-first digital platform, using advanced analytics for faster, more accurate decision-making, enabling earlier diagnosis and individualized treatment (Image: Business Wire)


​BerGenBio ASA Just Served Up Some Good News For Roche Holding AG Shareholders

Mark Collins | Equities.com |

Here's a look at this tiny Norwegian company's latest release and how it could affect Roche shareholders.


Roche Announces Acquisition of Ignyta for $1.7 Billion in Cash

Edward Kim | Equities.com |

$27 per share for Ignyta's precision oncology pipeline (Image: Medical News Today)


Denali Therapeutics Raises $250 Million in the Year's Largest Biotech IPO

Edward Kim | Equities.com |

Clinical pipeline targeting Parkinson's, Alzheimer's and ALS.


Mylan and Biocon Get Approval for First Biosimilar to Herceptin for Certain Breast and Stomach Cancers

Edward Kim | Equities.com |

First FDA-approved biosimilar to Roche's $2 billion drug (Image: Policy and Medicine).


Genentech Gets FDA Approval for Preventative Treatment of Hemophilia A

Edward Kim | Equities.com |

New treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors (Image: Genentech).


Roche Gets Expanded Label for Zelboraf to Include Erdheim-Chester Disease

Edward Kim | Equities.com |

First FDA-approved treatment for Erdheim-Chester Disease.


World Economic Forum at Davos 2019 - Joseph Weinberg CEO PayCase, Chairman Shyft

Matt Bird sits down with Joseph Weinberg CEO PayCase, Chairman Shyft at the World Economic Forum at Davos 2019


Events

Marketplace Lending and Alternative Financing Summit 2019

The Marketplace Lending and Alternative Financing Summit, hosted by Opal Financial Group, comes to Dana Point, CA this 8th-10th December. The Summit is an educational forum designed for investors, issuers,…

Learn more